DNMT3A have similar effects as a tumor suppressor in hematopoietic cells [132]; therefore, in 20–30% of various hematologic disorders Dnmt3a mutations seems to have a causal role in their development. The gene discussed is DNMT3A; the disease is hematologic disorder.